<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02949466</url>
  </required_header>
  <id_info>
    <org_study_id>MOST 105-2314-B-341-002</org_study_id>
    <nct_id>NCT02949466</nct_id>
  </id_info>
  <brief_title>Additional Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis</brief_title>
  <official_title>Additional Therapeutic Effects of Triamcinolone to Hyaluronic Acid on Knee Osteoarthritis: A Double Blind, Randomized-controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using a double-blind, randomized controlled design to investigate the additional therapeutic
      effects of 3 times of combined triamcinolone and hyaluronic acid injections to 3 times of
      hyaluronic acid injections to patients with knee osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 56 patients will be enrolled and randomized into two groups, including 3 times of
      triamcinolone combined hyaluronic acid injections group and 3 times of hyaluronic acid
      injections group.

      The triamcinolone combined hyaluronic acid injections group will receive 3 times of
      triamcinolone combined hyaluronic acid injection per week in three weeks; the hyaluronic acid
      group will receive hyaluronic acid injection in three weeks.

      Physical activities and functional performance will be evaluated at before injection, at
      after one week, one month, three months, and six months of completion of 3 times of
      injections.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional performance assessed with the Western Ontario and McMaster Universities Osteoarthritis Index</measure>
    <time_frame>changes from baseline to at after one week, one month, three months, and six months of completion of injections</time_frame>
    <description>Western Ontario and McMaster Universities Osteoarthritis Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>10 meter walk test</measure>
    <time_frame>changes from baseline to at after one week, one month, three months, and six months of completion of injections</time_frame>
    <description>10 meter walk as fast as possible</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed with the Knee Injury and Osteoarthritis Outcome Score</measure>
    <time_frame>changes from baseline to at after one week, one month, three months, and six months of completion of injections</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>5 times rapid chair rising test</measure>
    <time_frame>changes from baseline to at after one week, one month, three months, and six months of completion of injections</time_frame>
    <description>rapid chair rising for 5 times as fast as possible</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Physical Activity</condition>
  <condition>Functional Performance</condition>
  <arm_group>
    <arm_group_label>triamcinolone and hyaluronic acid group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>combined triamcinolone (Triamcinolone 10 mg 1cc) and hyaluronic acid (2 cc) injections: one injection per week, for 3 weeks, to compare the additional therapeutic effects of combined triamcinolone and hyaluronic acid injections to hyaluronic acid injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hyaluronic acid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>hyaluronic acid (2cc) injection: one injection per week, for 3 weeks, to compare the additional therapeutic effects of combined triamcinolone and hyaluronic acid injections to hyaluronic acid injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>compare the additional therapeutic effects of triamcinolone combined with hyaluronic acid injections to hyaluronic acid injections only to patients with knee osteoarthritis</description>
    <arm_group_label>triamcinolone and hyaluronic acid group</arm_group_label>
    <other_name>corticosteroids</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <description>compare the additional therapeutic effects of triamcinolone combined with hyaluronic acid injections to hyaluronic acid injections only to patients with knee osteoarthritis</description>
    <arm_group_label>triamcinolone and hyaluronic acid group</arm_group_label>
    <arm_group_label>hyaluronic acid group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  knee osteoarthritis with Kellgren/Lawrence grade II or III

        Exclusion Criteria:

          -  who have neurological deficit, such as stroke who have implant in knee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ru-Lan Hsieh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shin Kong Wu Ho-Su Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ru-Lan Hsieh, MD</last_name>
    <phone>886-2-28332211</phone>
    <phone_ext>2538;2531</phone_ext>
    <email>M001052@ms.skh.org.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ru-Lan Hsieh, MD</last_name>
    <phone>886-2-28332211</phone>
    <phone_ext>2538;2531</phone_ext>
    <email>rulan@tmu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shin Kong Wu Ho-Su Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>111-01</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2016</study_first_posted>
  <last_update_submitted>October 29, 2016</last_update_submitted>
  <last_update_submitted_qc>October 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University</investigator_affiliation>
    <investigator_full_name>Ru-Lan Hsieh</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>knee osteoarthritis</keyword>
  <keyword>triamcinolone</keyword>
  <keyword>therapeutic effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

